# Non-Muscle Invasive Bladder studies recruiting: 20 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 20 trials that are observational for Non-Muscle Invasive Bladder Neoplasms that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Non-Muscle Invasive Bladder Neoplasms studies: 20 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/non-muscle-invasive-bladder-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 20
- Recruiting or not yet: 20
- Read on: November 19, 2026

## Trials

The 20 newest of 20, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 26, 2026 | NCT07893509 | Outcomes for IR and High Risk (HR) Non-muscle Invasive Bladder Cancer (NMIBC) and ctDNA-based Biomarkers for Response and Recurrence in... | Bladder Cancer Advocacy Network | Observational | Not yet recruiting | NMIBC, MIBC, Muscle Invasive Bladder Cancer (MIBC), Non Muscle Invasive Bladder Cancer | 1,400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07893509) |
| August 13, 2026 | NCT07763197 | Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC) | Natera, Inc. | Observational | Recruiting | Non-Muscle Invasive Bladder Cancer, NMIBC, High-risk Non-Muscle Invasive Bladder Cancer | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07763197) |
| June 29, 2026 | NCT07673016 | Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer | Convergent Genomics, Inc. | Observational | Recruiting | Bladder Cancer, Urothelial Carcinoma (UC), Hematuria, Upper Tract Urothelial Cancer | 2,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07673016) |
| May 22, 2026 | NCT07602010 | Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer Staging | Oslo University Hospital | Observational | Recruiting | Bladder Cancer, Urothelial Carcinoma (UC), Muscle Invasive Bladder Cancer (MIBC), Non Muscle Invasive Bladder Cancer | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07602010) |
| April 14, 2026 | NCT07529639 | Tumor Budding and T1 Substaging in Urothelial Bladder Cancer | Assiut University | Observational | Not yet recruiting | Urothelial Bladder Carcinoma, Bladder Carcinoma, Non-Muscle-Invasive Bladder Cancer (NMIBC), Muscle-Invasive Bladder... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07529639) |
| March 27, 2026 | NCT07494864 | Effects of Microbiological and Immunological Factors on the Lower Urinary Tract | University of Zurich | Observational | Recruiting | Asymptomatic Bacteriuria in Subjects Not Requiring Assisted Bladder Emptying, Asymptomatic Bacteriuria in Subjects... | 800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07494864) |
| December 30, 2025 | NCT07309445 | A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United... | Janssen Research & Development, LLC | Observational | Recruiting | Non-Muscle Invasive Bladder Neoplasms | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07309445) |
| November 5, 2025 | NCT07225127 | Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2 | University of Washington | Observational | Recruiting | Bladder Cancer, Recurrent Bladder Cancer, Non-muscle Invasive Bladder Cancer (NMIBC) | 408 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07225127) |
| August 27, 2025 | NCT07144319 | Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy | Photocure | Observational | Recruiting | Bladder Cancer, Non-muscle Invasive Bladder Cancer | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07144319) |
| August 19, 2025 | NCT07130578 | The Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of High-risk Non-muscle Invasive... | Tianjin Medical University Second Hospital | Observational | Recruiting | Bladder Cancer, Liquid Biopsy | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07130578) |
| July 8, 2025 | NCT07053748 | Observational Clinical Study on High - Risk NMIBC Patients Choosing Trimodality Bladder - Sparing Therapy | Peking University First Hospital | Observational | Not yet recruiting | High - Risk NMIBC | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07053748) |
| May 28, 2025 | NCT06991868 | A Multicenter Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual... | Peking University First Hospital | Observational | Recruiting | NMIBC, MIBC, UTUC | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06991868) |
| December 12, 2023 | NCT06167356 | Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK. | IRCCS San Raffaele | Observational | Recruiting | Non Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Neoplasms, Non-Muscle Invasive Bladder Urothelial... | 20,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06167356) |
| April 24, 2023 | NCT05825950 | Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC) | University of Texas Southwestern Medical Center | Observational | Recruiting | Non-muscle-invasive Bladder Cancer | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05825950) |
| January 5, 2023 | NCT05672615 | Mood Alterations in the Patients With Non-Muscle Invasive Bladder Cancer Treated With BCG | Johns Hopkins University | Observational | Recruiting | Non-Muscle Invasive Bladder Cancer | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05672615) |
| April 20, 2022 | NCT05337397 | Outpatient Laser Ablation of Recurrent Non-muscle Invasive Bladder Cancer | Sponsor not shown (see the record) | Observational | Recruiting | Non-Muscle Invasive Bladder Cancer | 145 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05337397) |
| August 12, 2021 | NCT05002556 | AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer | Association Francaise d'Urologie | Observational | Recruiting | Non-Muscle-Invasive Bladder Cancer | 8,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05002556) |
| November 18, 2019 | NCT04167332 | Prospective Collection of Samples for Urothelial Cancer of Bladder | Universitaire Ziekenhuizen KU Leuven | Observational | Not yet recruiting | Bladder Cancer | 630 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04167332) |
| June 4, 2019 | NCT03973671 | Prospective Sample Collection for Cancer of Bladder | Universitaire Ziekenhuizen KU Leuven | Observational | Recruiting | Urinary Bladder Neoplasms | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03973671) |
| January 21, 2016 | NCT02660645 | Blue Light Cystoscopy With Cysview® Registry | Photocure | Observational | Recruiting | Bladder Cancer | 4,400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02660645) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [Photocure](https://specstream.ai/data/clinical-trials/company/photocure) | 2 |
| Peking University First Hospital | 2 |
| Universitaire Ziekenhuizen KU Leuven | 2 |
| Convergent Genomics, Inc. | 1 |
| Tianjin Medical University Second Hospital | 1 |
| Oslo University Hospital | 1 |
| IRCCS San Raffaele | 1 |
| University of Washington | 1 |
| Assiut University | 1 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 1 |
| [Natera, Inc.](https://specstream.ai/data/clinical-trials/company/natera-inc) | 1 |
| Johns Hopkins University | 1 |
| Bladder Cancer Advocacy Network | 1 |
| University of Zurich | 1 |
| Association Francaise d'Urologie | 1 |
| University of Texas Southwestern Medical Center | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 9 |
| Belgium | 2 |
| Norway | 2 |
| China | 2 |
| Puerto Rico | 1 |
| Canada | 1 |
| Germany | 1 |
| Italy | 1 |
| Denmark | 1 |
| Switzerland | 1 |
| France | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Wholesale florists in the United States](https://specstream.ai/data/businesses/wholesale-florists/united-states)
- [Bathroom remodelers in the United States](https://specstream.ai/data/businesses/bathroom-remodelers/united-states)
- [Cuban restaurants in the United States](https://specstream.ai/data/businesses/cuban-restaurants/united-states)
- [Foundation repair contractors in the United States](https://specstream.ai/data/businesses/foundation-repair-contractors/united-states)
- [Korean restaurants in the United States](https://specstream.ai/data/businesses/korean-restaurants/united-states)
- [Pathology practices in the United States](https://specstream.ai/data/businesses/pathology-practices/united-states)
